Capital Analysts LLC lifted its stake in shares of AmerisourceBergen Corp. (NYSE:ABC) by 12,686.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 47,822 shares of the company’s stock after purchasing an additional 47,448 shares during the quarter. Capital Analysts LLC’s holdings in AmerisourceBergen were worth $4,091,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. Vantage Investment Advisors LLC acquired a new stake in shares of AmerisourceBergen during the 4th quarter worth approximately $156,000. Intl Fcstone Inc. acquired a new stake in shares of AmerisourceBergen during the 2nd quarter worth approximately $201,000. TRUE Private Wealth Advisors acquired a new stake in AmerisourceBergen in the 4th quarter valued at approximately $203,000. Zeke Capital Advisors LLC acquired a new stake in AmerisourceBergen in the 3rd quarter valued at approximately $210,000. Finally, IBM Retirement Fund acquired a new stake in AmerisourceBergen in the 4th quarter valued at approximately $216,000. Institutional investors and hedge funds own 65.98% of the company’s stock.
AmerisourceBergen Corp. (NYSE:ABC) opened at $98.57 on Thursday. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.50 and a current ratio of 0.95. The stock has a market capitalization of $21,953.72, a price-to-earnings ratio of 16.44, a price-to-earnings-growth ratio of 1.60 and a beta of 1.02. AmerisourceBergen Corp. has a one year low of $71.90 and a one year high of $106.27.
AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.35 by $0.20. The firm had revenue of $40.47 billion during the quarter, compared to analyst estimates of $40.42 billion. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period last year, the company posted $1.36 EPS. equities research analysts predict that AmerisourceBergen Corp. will post 6.58 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be paid a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date of this dividend is Friday, February 16th. AmerisourceBergen’s payout ratio is currently 32.76%.
ABC has been the topic of several analyst reports. Credit Suisse Group restated an “outperform” rating and issued a $112.00 target price (up from $105.00) on shares of AmerisourceBergen in a research report on Wednesday, February 7th. They noted that the move was a valuation call. Needham & Company LLC raised their target price on AmerisourceBergen from $86.00 to $88.00 and gave the company a “buy” rating in a research report on Wednesday, November 22nd. Mizuho set a $100.00 target price on AmerisourceBergen and gave the company a “hold” rating in a research report on Wednesday, January 24th. Robert W. Baird restated a “buy” rating and issued a $96.00 target price on shares of AmerisourceBergen in a research report on Monday, November 6th. Finally, TheStreet upgraded AmerisourceBergen from a “c” rating to a “b” rating in a research report on Tuesday, February 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $101.17.
In other AmerisourceBergen news, insider Dale Danilewitz sold 21,500 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $97.30, for a total transaction of $2,091,950.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard W. Gochnauer sold 2,000 shares of the stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $85.00, for a total value of $170,000.00. Following the transaction, the director now directly owns 12,947 shares of the company’s stock, valued at $1,100,495. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 222,396 shares of company stock valued at $20,261,915. 27.30% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “Capital Analysts LLC Increases Stake in AmerisourceBergen Corp. (ABC)” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/02/22/capital-analysts-llc-increases-stake-in-amerisourcebergen-corp-abc.html.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.